Azopharma



Who is Azopharma?

We are a contract pharmaceutical development organization that helps turn ideas into cures with a complete spectrum of CMC solutions for pharmaceutical development. View more...

Accu-Break
Accu-Break Pharmaceuticals, Inc. and Azopharma Product Development Group, Inc. have formed a strategic alliance to provide patented and patent pending tablet technologies and development services to the pharmaceutical industry.

For more information click here

Preclinical Services
Azopharma provides preclinical metabolism and toxicology services to support your IND filing.


Synthetic Services
Azopharma offers custom synthesis in support of pharmaceutical product development from milligram to kilogram quantities.


Active Pharmaceutical Ingredients
Azopharma has custom synthesis capabilities to manufacture cGMP supplies of active pharmaceutical ingredients.


Characterization Services
From impurity identification to primary reference standards, our synthetic, organic and analytical chemists can assist with routine or challenging characterization projects.


Large Molecule Capabilities
Azopharma provides specialized services specific to the needs of the Biotechnology industry.


Preformulation Services
We specialize in the design and execution of pertinent preformulation activities required for successful pharmaceutical product development.


Formulation Development
Azopharma offers formulations development for dosage forms including Solid Oral, Semi-Solids, Liquids and other non-traditional dosage forms.


Methods Development & Validation
Azopharma's holistic approach to analytical methods development and validation, whether routine or non-routine, ensures compliance with today's industry standards.


QC and Microbiology Testing
Azopharma offers quality control (QC) testing for Active Pharmaceutical Ingredients (API's), pharmaceutical intermediates, excipients, and finished products.


Stability Studies
Core services at Azopharma for management of stability programs are geared towards high throughput production combined with detailed compliance strategies.


CTM Manufacturing and Packaging
Azopharma’s cGMP facilities, experienced team and unique approach to CTM manufacturing give our sponsors an opportunity to accelerate development of their lead compounds.


Product Development Services- Phase I Express™
Azopharma's proprietary approach for expediting drug development for new compounds entering clinical development activities.


Contract Manufacturing
Azopharma operates manufacturing facilities and provides services to accelerate development, scale-up and commercialization for numerous dosage forms.


Cytotoxic and Potent Compound Formulation
Azopharma has multiple containment suites for developing and manufacturing potent and cytotoxic drug compounds.


Inhalation Capabilities
Azopharma’s inhalation and intranasal formulations development group assists our partners with the development of various inhalation dosage forms.


Regulatory Consulting
We can help navigate the regulatory hurdles associated with drug development and to facilitate approval of submissions by international regulatory authorities.


Bioanalytical
Our GLP compliant operations are equipped to analyze biological samples for drug candidates and metabolites in various biological matrices.


Drug Delivery Technology
Azopharma’s drug development efforts are based on technology platforms including bioavailability enhancement of poorly soluble drugs and the development of customized release profiles.


Clinical Pharmacology
Azopharma’s new state of the art clinical pharmacology research unit brings together an impressive blend of experience and services to support studies across virtually every therapeutic indication.


Scripter

job.gif

Press Release
November 11, 2008

Azopharma Unveils New UK Laboratory and EU Plans

HOLLYWOOD, Fla. – Azopharma Product Development GroupTM is pleased to announce its entrance into the European market with the addition of new laboratory facilities and office space located in Welwyn Garden City, UK. The new facility will provide analytical, QP release testing, preformulation and formulation development services to the European market. Mr. Phil Meeks, CEO of Azopharma Product Development Group says, “This is a very exciting time for Azopharma with our first venture outside the USA. Our vision for the new laboratory is to provide key product development services to our many clients in Europe. We see this facility as the first step in bringing our complete service offerings to the region.”

Read More...

Trade Shows

Pittcon, Chicago
March 9-12

Tox Expo, Baltimore
March 15-18

DCAT, New York City
March 16-20

Interphex, New York City
March 17-19

DIA Europe, Berlin March 23-25
Copyright 2002-2006 Azopharma, Inc   Terms Of Use  Privacy Statement